O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer
Title:
O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer
Author:
Van Cutsem, E. Taieb, J. Yaeger, R. Yoshino, T. Maiello, E. Elez, E. Dekervel, J. Ross, P. Ruiz Casado, A. Graham, J. Kato, T. Ruffinelli, J. André, T. Carriere Roussel, E. Klauck, I. Groc, M. Grothey, A. Vedovato, J. Tabernero, J.